Is Aktis Oncology, Inc. overvalued?

Aktis Oncology, Inc. (AKTS) — key valuation metrics and fundamentals.

No verdict

Price

$24.45

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$1.31B

Dividend yield

0.0%

Return on equity

-44.1%

Sector

Healthcare

Fair value compares AKTS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks